Tirzepatide Zepbound® - Injectable
US$ 20.85
tirzepatide journal club SURMOUNT-1 Trial Clinical Impact of Tirzepatide on
Description
Our healthcare professionals will guide you through the recommended dosing schedule, which involves gradual dose escalations to enhance your bodys tolerance and minimize side effects
ZEPBOUND is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]
Adult Obesity Facts
Both drugs help manage Type 2 diabetes, but taking two GLP-1 medications at the same time is not recommended
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
Lancet Diabetes Endocrinol 10(6):418429
